(Q44446577)

3 December 2017

title

Metabolism of levamisole, an anti-colon cancer drug, by human intestinal bacteria (English)

1 reference

3 December 2017

1 reference

Shu YZ

1

1 reference

3 December 2017

Kingston DG

series ordinal

2

1 reference

3 December 2017

Van Tassell RL

series ordinal

3

1 reference

3 December 2017

Wilkins TD

series ordinal

4

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 June 1991

1 reference

3 December 2017

1 reference

3 December 2017

volume

21

1 reference

3 December 2017

issue

6

1 reference

3 December 2017

page(s)

737-750

1 reference

Levamisole and immunotherapy: some theoretic and practical considerations and their relevance to human disease

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00498259109039513

Anaerobic metabolism of 2-amino-3-methyl-3H-imidazo[4,5-f]quinoline (IQ) by human fecal flora

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498259109039513

DL-2-Oxo-3-(2-mercaptoethyl)-5-phenylimidazolidine. A sulfhydryl metabolite of levamisole that interacts with microtubules

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498259109039513

Novel assay and pharmacokinetics of levamisole and p-hydroxylevamisole in human plasma and urine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498259109039513

The general immunopharmacology of levamisole

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498259109039513

10.3109/00498259109039513

21 January 2018

Identifiers

DOI

1 reference

3 December 2017

1 reference